Genetics of Antimicrobial Resistance — MCQs
What is the primary mechanism of antibiotic resistance in Neisseria gonorrhoeae?
Which of the following is the most clinically significant function of plasmids in antimicrobial resistance?
Drug resistance is not transmitted by-
Which bacterial component is critical for the antibiotic resistance of N. gonorrhoeae to penicillin?
Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
Which of the following is the most effective method to prevent malaria?
Hypercoagulability due to a defective factor V gene is called:
Which of the following best describes the current understanding of rosacea pathogenesis?
Transmission of R factor is by which mechanism?
Resistance to drugs in tuberculosis develops by which mechanism?
Genetics of Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Question 1: What is the primary mechanism of antibiotic resistance in Neisseria gonorrhoeae?
- A. Efflux pump mechanisms only
- B. Altered penicillin-binding proteins (PBPs) (Correct Answer)
- C. Ribosomal protection proteins only
- D. Plasmid-mediated beta-lactamase production only
Explanation: ***Altered penicillin-binding proteins (PBPs)*** - Alterations in **penicillin-binding proteins (PBPs)**, particularly the mosaic *penA* gene, represent the **most clinically significant mechanism** of resistance in *N. gonorrhoeae* today. - These chromosomal mutations reduce the affinity of beta-lactam antibiotics (including **cephalosporins**) for their target, preventing inhibition of cell wall synthesis. - This mechanism is responsible for **reduced susceptibility and resistance to extended-spectrum cephalosporins** (ceftriaxone, cefixime), which are currently the recommended first-line treatment. - PBP alterations are now **widespread globally** and represent the primary concern for treatment failure. *Plasmid-mediated beta-lactamase production only* - Beta-lactamase production (PPNG strains) was historically important for **penicillin resistance** in the 1970s-1980s. - While still present, this mechanism is **less relevant clinically** today since penicillin is no longer used for gonorrhea treatment. - The word "only" makes this incorrect, as *N. gonorrhoeae* employs multiple resistance mechanisms simultaneously. *Efflux pump mechanisms only* - The **MtrCDE efflux pump system** contributes to resistance by expelling multiple antibiotic classes from the bacterial cell. - Efflux pumps enhance resistance to **hydrophobic antibiotics** including azithromycin and some beta-lactams. - However, they are typically part of a **multifactorial resistance pattern** rather than the sole mechanism, making "only" incorrect. *Ribosomal protection proteins only* - Ribosomal protection (e.g., *tetM* gene) confers resistance to **tetracyclines**. - This mechanism is important for tetracycline resistance but is **not the primary concern** for current gonorrhea treatment. - The word "only" makes this incorrect, as resistance involves multiple mechanisms.
Question 2: Which of the following is the most clinically significant function of plasmids in antimicrobial resistance?
- A. Involved in multidrug resistance transfer (Correct Answer)
- B. Involved in conjugation
- C. Imparts capsule formation
- D. Imparts pili formation
Explanation: ***Involved in multidrug resistance transfer*** - **R-plasmids (resistance plasmids)** carry genes that provide bacteria with resistance to multiple antibiotics simultaneously. - These resistance genes can be transferred horizontally between bacteria through conjugation, transformation, or transduction, contributing to the rapid spread of **multidrug-resistant infections**. - This is the most **clinically significant** function of plasmids in medical microbiology. *Involved in conjugation* - While **F-plasmids (fertility plasmids)** encode the machinery for bacterial conjugation, this is a specific function of fertility plasmids rather than the primary clinical concern. - Conjugation is the mechanism by which plasmids (including R-plasmids) transfer between bacteria, but the question asks about the function most relevant to antimicrobial resistance. *Imparts capsule formation* - **Capsule formation** is typically encoded by genes on the **bacterial chromosome**, not plasmids. - Capsule genes are part of the core bacterial genome and represent a stable chromosomal trait. *Imparts pili formation* - While **sex pili** involved in conjugation can be plasmid-encoded (by F-plasmids), most **common pili** (fimbriae) involved in adhesion are chromosomally encoded. - This is not the primary clinically significant function of plasmids in the context of antimicrobial resistance.
Question 3: Drug resistance is not transmitted by-
- A. Plasmids
- B. Ribosomes (Correct Answer)
- C. Chromosomes
- D. Transposons
Explanation: ***Ribosomes*** - Ribosomes are responsible for **protein synthesis** and do not carry or transmit genetic information for **drug resistance**. - While ribosomal mutations can sometimes lead to drug resistance, the ribosome itself is not a vehicle for its transmission between bacteria. *Plasmids* - **Plasmids** are small, extrachromosomal DNA molecules that can replicate independently and are a primary means of **horizontal gene transfer** for drug resistance genes. - They can be easily transferred between bacteria through **conjugation**, rapidly spreading resistance. *Chromosomes* - **Drug resistance genes** can be located on the bacterial chromosome and are passed down to daughter cells during **vertical gene transfer** (cell division). - While less frequent for initial acquisition compared to plasmids, chromosomal mutations and integrated resistance genes are significant causes of **antibiotic resistance**. *Transposons* - **Transposons**, or jumping genes, are DNA sequences that can move from one location in the genome to another, including between **plasmids and chromosomes**. - They often carry **antibiotic resistance genes** and facilitate their spread within a bacterial genome or between different genetic elements.
Question 4: Which bacterial component is critical for the antibiotic resistance of N. gonorrhoeae to penicillin?
- A. Beta-lactamase enzyme
- B. Ribosomal protection proteins
- C. Efflux pump system
- D. Altered PBP2 (penA gene mutations) (Correct Answer)
Explanation: ***Altered PBP2 (penA gene mutations)*** - **Mutations in the *penA* gene** lead to changes in **penicillin-binding protein 2 (PBP2)**, reducing its affinity for penicillin and other beta-lactam antibiotics. - This reduced binding affinity prevents penicillin from effectively inhibiting **cell wall synthesis**, allowing *N. gonorrhoeae* to resist its bactericidal effects. *Beta-lactamase enzyme* - While beta-lactamase (specifically **penicillinase**) produced by some *N. gonorrhoeae* strains can **hydrolyze the beta-lactam ring** of penicillin, it is not the *critical* and most prevalent mechanism for **high-level penicillin resistance** in current strains. - The evolution of resistance has largely shifted from beta-lactamase production to **PBP mutations**. *Ribosomal protection proteins* - These proteins are primarily associated with resistance to **macrolide antibiotics** and tetracyclines, not penicillins. - They work by binding to the ribosome and **preventing antibiotic interference** with protein synthesis. *Efflux pump system* - Efflux pumps contribute to resistance by actively **expelling antibiotics** from the bacterial cell, thereby preventing them from reaching their intracellular targets. - While efflux pumps can play a role in **multi-drug resistance**, they are not the primary mechanism for penicillin resistance in *N. gonorrhoeae*.
Question 5: Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
- A. Quinolone (Correct Answer)
- B. Penicillin
- C. Chloramphenicol
- D. Aminoglycoside
Explanation: ***Quinolone*** - The primary mechanisms of resistance to **quinolones** involve mutations in the **gyrase** and **topoisomerase IV** enzymes or efflux pump overexpression, rather than enzymatic inactivation of the drug itself. - Unlike other antibiotic classes listed, quinolones are not typically susceptible to bacterial enzymes that degrade or modify their structure. *Penicillin* - **Penicillins** are highly susceptible to inactivation by **beta-lactamase enzymes**, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective. - This enzymatic degradation is a major mechanism of resistance developed by many bacterial species to penicillin and other beta-lactam antibiotics. *Chloramphenicol* - Resistance to **chloramphenicol** is primarily mediated by the enzyme **chloramphenicol acetyltransferase (CAT)**, which acetylates the drug, preventing its binding to the bacterial ribosome. - This enzymatic modification is a classic example of drug inactivation leading to resistance. *Aminoglycoside* - **Aminoglycosides** are frequently inactivated by a variety of **aminoglycoside-modifying enzymes (AMEs)**, such as acetyltransferases, phosphoryltransferases, and nucleotidyltransferases. - These enzymes add chemical moieties to the aminoglycoside molecule, preventing its binding to the bacterial ribosome and inhibiting protein synthesis.
Question 6: Which of the following is the most effective method to prevent malaria?
- A. Use of insecticide-treated nets (Correct Answer)
- B. Vaccination
- C. Antimalarial drugs
- D. Genetic modification of mosquitoes
Explanation: ***Use of insecticide-treated nets*** - **Insecticide-treated nets (ITNs)** provide a physical barrier against mosquitoes and kill mosquitoes that come into contact with the net. This dual action makes them highly effective, especially for vulnerable populations sleeping at night when **Anopheles mosquitoes** are most active. - Widespread distribution and proper use of ITNs have been shown to significantly reduce **malaria incidence** and mortality in endemic areas, making them a cornerstone of malaria prevention programs. *Vaccination* - The **RTS,S/AS01 (Mosquirix)** vaccine is the first and only vaccine recommended for broad use against malaria, primarily for children in regions with moderate to high transmission. - While a significant breakthrough, its efficacy is **moderate** (around 30-40% against severe malaria in children) and it requires multiple doses, making it less singularly effective than ITNs at a population level for immediate prevention. *Antimalarial drugs* - **Antimalarial drugs** are primarily used for treatment, but can also be used for **chemoprophylaxis** (preventive treatment) in travelers or specific vulnerable groups (e.g., pregnant women, infants). - While effective for individual prevention when taken consistently, mass drug administration for prevention faces challenges such as **drug resistance**, cost, adherence, and potential side effects, limiting its widespread and long-term population-level effectiveness compared to ITNs. *Genetic modification of mosquitoes* - **Genetic modification of mosquitoes** (e.g., using gene drive technology to introduce sterility or make mosquitoes resistant to carrying the parasite) is an emerging and promising research area. - This method is still in **experimental stages**, with significant ethical, ecological, and regulatory hurdles to overcome before it can be implemented as a widespread, effective prevention strategy.
Question 7: Hypercoagulability due to a defective factor V gene is called:
- A. Lisbon mutation
- B. Antiphospholipid syndrome
- C. Inducible thrombocytopenia syndrome
- D. Leiden mutation (Correct Answer)
Explanation: ***Leiden mutation*** - The **Leiden mutation** refers specifically to a mutation in the **factor V gene** that leads to a hypercoagulable state, particularly increasing the risk of venous thromboembolism [1]. - It causes resistance to **activated protein C**, which normally regulates blood clotting, thus contributing to sustained clot formation [1]. *Lisbon mutation* - The **Lisbon mutation** is not a recognized term in the context of coagulation disorders or factor V. - There is no clinical relevance tied to clotting abnormalities related specifically to this mutation in the scientific literature. *Antiphospholipid syndrome* - Antiphospholipid syndrome is an autoimmune disorder characterized by **thrombosis** and pregnancy complications, but not specifically linked to the **factor V gene**. - It involves antibodies against phospholipids, which is unrelated to the genetic mutations affecting factor V. *Inducible thrombocytopenia syndrome* - This syndrome primarily involves **low platelet counts** induced by certain medications or conditions, not a defect in **factor V**. - It does not relate to hypercoagulability but rather to bleeding risks due to the **decreased platelet count**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 133-134.
Question 8: Which of the following best describes the current understanding of rosacea pathogenesis?
- A. Primarily caused by increased sebum production similar to acne vulgaris
- B. Solely due to increased reactivity of cutaneous blood vessels to vasodilators
- C. Multifactorial etiology with no single definitive cause established (Correct Answer)
- D. Results from bacterial infection affecting the entire face and back
Explanation: ***Multifactorial etiology with no single definitive cause established*** - Rosacea is understood to arise from complex interactions between **genetic predisposition**, **environmental triggers**, **immune dysregulation**, and **neurovascular dysfunction**. - No single factor fully explains its development; rather, it's a **synergistic interplay** of multiple pathways. *Primarily caused by increased sebum production similar to acne vulgaris* - While sebaceous glands can be affected in phymatous rosacea, **increased sebum production** is the primary driver of **acne vulgaris**, not rosacea. - Rosacea is fundamentally a disorder of **neurovascular and immune dysregulation**, not primarily of follicular obstruction or sebum overproduction. *Solely due to increased reactivity of cutaneous blood vessels to vasodilators* - While **vascular dysfunction** and increased reactivity to vasodilators are significant components of rosacea, they are not the sole causative factor. - **Inflammation**, genetic factors, and immune system involvement also play crucial roles. *Results from bacterial infection affecting the entire face and back* - Rosacea is not solely caused by a **bacterial infection**, although the **skin microbiome** (e.g., *Demodex mites*, *Bacillus oleronius*) may contribute to inflammation in some cases. - Unlike conditions like **acne**, which is linked to *Cutibacterium acnes*, rosacea is not considered a primary bacterial infection.
Question 9: Transmission of R factor is by which mechanism?
- A. Conjugation (Correct Answer)
- B. Transduction
- C. Transformation
- D. Lysogenic conversion
Explanation: **Explanation:** **Why Conjugation is Correct:** The **R factor (Resistance factor)** is a type of plasmid that carries genes for antibiotic resistance. It consists of two components: the **Resistance Transfer Factor (RTF)**, which contains genes for autonomous replication and conjugative transfer, and the **r-determinant**, which carries the actual resistance genes. The primary mechanism for the spread of R factors between bacteria (especially Gram-negative bacilli like *E. coli* and *Salmonella*) is **Conjugation**. This process involves direct cell-to-cell contact via a sex pilus, allowing the rapid horizontal transfer of multi-drug resistance across different bacterial species. **Why Other Options are Incorrect:** * **Transduction:** This involves the transfer of DNA via a **bacteriophage** (virus). While some resistance genes (like those for Penicillinase in *Staphylococci*) can be transduced, the large R factor plasmid is typically transferred via conjugation. * **Transformation:** This is the uptake of **naked DNA** from the environment. It is a significant mechanism for species like *S. pneumoniae* and *Neisseria*, but it is not the classic route for R factor transmission. * **Lysogenic Conversion:** This occurs when a temperate phage integrates into the bacterial chromosome (prophage), imparting new phenotypic traits (e.g., **Diphtheria toxin**, Cholera toxin, or Erythrogenic toxin). It does not involve R factor transfer. **High-Yield Clinical Pearls for NEET-PG:** * **R Factor:** Responsible for "Infectious Drug Resistance." One R factor can carry resistance to multiple drugs (e.g., Sulfonamides, Streptomycin, Chloramphenicol). * **Conjugation:** The most common method for the spread of multidrug resistance in clinical settings. * **Transposons ("Jumping Genes"):** These are DNA sequences that can move from a plasmid to a chromosome (or vice versa) and are often found within R factors.
Question 10: Resistance to drugs in tuberculosis develops by which mechanism?
- A. Transduction
- B. Conjugation
- C. Transformation
- D. Mutation (Correct Answer)
Explanation: **Explanation:** In *Mycobacterium tuberculosis* (MTB), drug resistance is primarily driven by **spontaneous genetic mutations** in specific chromosomal genes. Unlike many other bacteria, MTB does not possess horizontal gene transfer mechanisms like plasmids or transposons. **1. Why Mutation is Correct:** Resistance in MTB occurs due to random, stepwise mutations in the chromosomal DNA. When a patient is treated with inadequate monotherapy or irregular dosing, these resistant mutants are "selected" and multiply (selective pressure). * **High-yield examples:** * **Isoniazid (INH) resistance:** Mutations in the *katG* gene (loss of catalase-peroxidase activity) or *inhA* gene. * **Rifampicin resistance:** Mutations in the *rpoB* gene (beta-subunit of RNA polymerase). **2. Why Other Options are Incorrect:** * **Transduction (A):** Involves DNA transfer via a bacteriophage. While mycobacteriophages exist, they do not play a role in clinical drug resistance. * **Conjugation (B):** Involves cell-to-cell contact via a sex pilus to transfer plasmids. MTB lacks the plasmids necessary for this process. * **Transformation (C):** Involves the uptake of free "naked" DNA from the environment. This is not a documented mechanism for resistance in MTB. **Clinical Pearls for NEET-PG:** * **Multidrug-Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid and Rifampicin**. * **Extensively Drug-Resistant TB (XDR-TB):** MDR-TB plus resistance to any **fluoroquinolone** and at least one **Group A drug** (Bedaquiline or Linezolid). * **Genotypic Testing:** Molecular methods like **GeneXpert (CBNAAT)** and **Line Probe Assay (LPA)** detect resistance by identifying these specific chromosomal mutations (e.g., *rpoB* for Rifampicin).
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free